Global Viral Gastroenteritis Market Forecast Report 2025-2034


 The Business Research Company's report on the Viral Gastroenteritis Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.


Which emerging drivers are set to accelerate the growth of the viral gastroenteritis market further?
The increasing prevalence of gastrointestinal disorders is expected to propel the growth of the viral gastroenteritis market going forward. Gastrointestinal (GI) disorders refer to a disease that occurs within or on any part of the gastrointestinal tract. Viral gastroenteritis drugs and diagnosis treatments help people suffering from the illness with proper and appropriate medication. For instance, in September 2023, according to the Impact of IBD Report 2023 published by the IBD Clinical and Research Centre, a Canada-based organization that aims to improve the lives of patients with Crohn's disease and ulcerative colitis, with a prevalence of 825 per 100,000 in 2023, over 320,000 people in Canada have inflammatory bowel disease (IBD), and as the prevalence is expected to increase by 2.44% annually, 1.1% of the population, or 470,000 Canadians, is projected to be living with IBD by 2035. Therefore, the increasing prevalence of gastrointestinal disorders is driving the growth of the viral gastroenteritis market.

Access Your Free Sample of the Global Viral Gastroenteritis Market Report – Get Insights Now!
Global Viral Gastroenteritis Market Forecast Report 2025-2034 Sample

What are the key factors influencing the forecasted market size of the viral gastroenteritis industry?
The viral gastroenteritis market size has grown steadily in recent years. It will grow from $6.75 billion in 2024 to $7.08 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to the prevalence of viral infections, global hygiene practices, advancements in diagnostics, global travel and tourism, and climate and environmental factors

The viral gastroenteritis market size is expected to see strong growth in the next few years. It will grow to $8.73 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to global health preparedness, climate change impact, one health approach, epidemiological surveillance systems, education and public awareness. Major trends in the forecast period include vaccine development, advanced diagnostics, telemedicine in diagnosis, collaborative research initiatives, personalized medicine approaches, and digital health solutions.

Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
Global Viral Gastroenteritis Market Forecast Report 2025-2034 Customise

Who are the leading competitors in the viral gastroenteritis market?
Major companies operating in the viral gastroenteritis market include Pfizer Inc., Abbvie Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Alexion Pharmaceuticals Inc., Horizon Therapeutics Plc, Dr. Reddy’s Laboratories Ltd., BioMarin Pharmaceutical Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, Ironwood Pharmaceuticals Inc, ANI Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Allergan plc, Haustus Biotech Private Limited, Gracia Lifesciences India Private Limited

Which emerging trends are set to transform the viral gastroenteritis market landscape?
Product innovation is the key trend gaining popularity in the viral gastroenteritis market. Major companies operating in the viral gastroenteritis market are focusing on developing new products to strengthen their position in the market. For instance, in November 2022, GlaxoSmithKline PLC, a UK-based biopharmaceutical company, received approval from the US Food and Drug Administration (FDA) for its oral-dosing applicator-only presentation (liquid formulation) of ROTARIX to prevent rotavirus gastroenteritis in infants. This new presentation formulation becomes more convenient for healthcare providers by eliminating the need to reconstitute the vaccine dose at the point of use. The approval is supported by international clinical trial data demonstrating safety and tolerability compared to the lyophilized formulation and non-inferiority of immunogenicity.

How do different geographies compare in terms of market share and growth potential in the viral gastroenteritis market?
North America was the largest region in the viral gastroenteritis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Order Your Report Now For Swift Delivery
Global Viral Gastroenteritis Market Forecast Report 2025-2034

Which major segments of the viral gastroenteritis market are experiencing the fastest growth?
The viral gastroenteritis market covered in this report is segmented –

1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs
2) By Diagnosis: Physical Examination, Rapid Stool Test
3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications
4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus
5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins
2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate
3) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners
4) By Antimotility Agents: Loperamide, Diphenoxylate
5) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics

Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
Global Viral Gastroenteritis Market Forecast Report 2025-2034

How is the viral gastroenteritis market defined, and what are its core characteristics?
Viral gastroenteritis is an intestinal viral infection characterized by swelling, irritation, and inflammation of the inner lining of your gastrointestinal tract. The signs and symptoms include watery diarrhea, nausea or vomiting, stomach cramps, and a fever.

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

Market Research Reports

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info


Follow Us On:

LinkedIn: The Business Research Company | LinkedIn

Comments

Popular posts from this blog

10.8% Surge in Insurance Advertising Market Growth: Forecasted to Cross $21.34 Billion by 2029

Artificial intelligence (AI) In Home Automation Market Report 2025 – Strategic Data for Growth and Expansion

The Future of Interactive Whiteboard Market Size and Growth: Trends, Drivers, and Opportunities